Registres
Chaque registre et chaque liste historique, avec son nombre d’enregistrements et quelques-uns d’entre eux.
Canada
Health Canada · 27 enregistrements
- Tri-Cira 210.035 MG + 0.035 MG + 0.035 MG + 0.215 MG + 0.25 MG + 0.18 MG · Tablet · Apotex INC
- Tri-Cira 280.035 MG + 0.035 MG + 0.035 MG + 0.18 MG + 0.25 MG + 0.215 MG · Tablet · Apotex INC
- Tri-Cira Lo 210.025 MG + 0.025 MG + 0.025 MG + 0.215 MG + 0.25 MG + 0.18 MG · Tablet · Apotex INC
- Tri-Cira Lo 280.025 MG + 0.025 MG + 0.025 MG + 0.215 MG + 0.18 MG + 0.25 MG · Tablet · Apotex INC
États-Unis
FDA · 24 enregistrements
- Estarylla0.035MG; 0.25MG · tablet · Xiromed
- Mili0.035MG; 0.25MG · tablet · Aurobindo Pharma LTD
- Mono-Linyah0.035MG; 0.25MG · tablet · Novast Labs LTD
- Norgestimate and Ethinyl Estradiol0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG, 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG, 0.035MG; 0.25MG · tablet · Lupin
Espagne
AEMPS · 3 enregistrements
En bref
- Registres
- 6
- Listes historiques
- 1
- Enregistrements
- 59
- Avec leur propre page
- 31
- Laboratoires
- 24
Tous les médicaments contenant Norgestimate
Les médicaments à usage humain de tous les registres qui correspondent à Norgestimate par la substance ou par le nom, page par page ; leur nombre peut donc différer des enregistrements ci-dessus. Dosages et conditionnements figurent sur la page de chaque médicament.
61 résultats de recherche
| Médicament | Registre | Dosage | Forme | Statut | Titulaire |
|---|---|---|---|---|---|
| Norgestimate; Ethinyl EstradiolAssociation | États-Unis | 0.215MG; 0.025MG, 0.215MG; 0.035MG, 0.25MG; 0.025MG … | tablet | Commercialisé | Glenmark Pharms LTD |
| Norgestimate and Ethinyl EstradiolAssociation | États-Unis | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG, 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG, 0.035MG; 0.25MG | tablet | Commercialisé | Lupin |
| Norgestimaat/Ethinylestradiol Xiromed 0,25 mg/0,035 mg tablettenAssociation | Pays-Bas | Tablet | Autorisé | Medical Valley Invest AB | |
| EstaryllaAssociation | États-Unis | 0.035MG; 0.25MG | tablet | Commercialisé | Xiromed |
| Tri-EstaryllaAssociation | États-Unis | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Commercialisé | Xiromed |
| Tri-Lo-EstaryllaAssociation | États-Unis | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG | tablet | Commercialisé | Xiromed |
| Estradiol and NorgestimateAssociation | États-Unis | 1MG,1MG; 0.09MG | tablet | Non commercialisé | Barr |
| MiliAssociation | États-Unis | 0.035MG; 0.25MG | tablet | Commercialisé | Aurobindo Pharma LTD |
| Mono-LinyahAssociation | États-Unis | 0.035MG; 0.25MG | tablet | Commercialisé | Novast Labs LTD |
| SprintecAssociation | États-Unis | 0.035MG; 0.25MG | tablet | Commercialisé | Barr |
| Tri-LinyahAssociation | États-Unis | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Commercialisé | Novast Labs LTD |
| Tri-Lo-MiliAssociation | États-Unis | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG | tablet | Commercialisé | Aurobindo Pharma |
| Tri Lo SprintecAssociation | États-Unis | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG | tablet | Commercialisé | Barr Labs INC |
| Tri-MiliAssociation | États-Unis | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Commercialisé | Aurobindo Pharma LTD |
| Tri-SprintecAssociation | États-Unis | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Commercialisé | Barr |
| Edelsine 0,250/0,035 MG ComprimidosAssociation | Espagne | 0,250 mg + 0,035 mg | comprimido | Commercialisé | Laboratorios Effik S.A. |
| Ortho Tri-Cyclen 21Association | États-Unis | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Commercialisé | Ortho Mcneil Pharm |
| Ortho Tri-Cyclen 28Association | États-Unis | 0.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MG | tablet | Commercialisé | Ortho Mcneil Pharm |
| Tri-Lo-LinyahAssociation | États-Unis | 0.025MG,0.025MG,0.025MG; 0.18MG,0.215MG,0.25MG | tablet | Commercialisé | Novast Labs |
| Tri-Cira 21Association | Canada | 0.035 MG + 0.035 MG + 0.035 MG + 0.215 MG + 0.25 MG + 0.18 MG | Tablet | Commercialisé | Apotex INC |
| Tri-Cira 28Association | Canada | 0.035 MG + 0.035 MG + 0.035 MG + 0.18 MG + 0.25 MG + 0.215 MG | Tablet | Commercialisé | Apotex INC |
| Tri-Cira Lo 21Association | Canada | 0.025 MG + 0.025 MG + 0.025 MG + 0.215 MG + 0.25 MG + 0.18 MG | Tablet | Commercialisé | Apotex INC |
| Tri-Cira Lo 28Association | Canada | 0.025 MG + 0.025 MG + 0.025 MG + 0.215 MG + 0.18 MG + 0.25 MG | Tablet | Commercialisé | Apotex INC |
| Tri-Jordyna 21Association | Canada | 0.035 MG + 0.035 MG + 0.035 MG + 0.18 MG + 0.25 MG + 0.215 MG | Tablet | Commercialisé | Glenmark Pharmaceuticals Canada INC. |
| Tri-Jordyna 28Association | Canada | 0.035 MG + 0.035 MG + 0.035 MG + 0.18 MG + 0.25 MG + 0.215 MG | Tablet | Commercialisé | Glenmark Pharmaceuticals Canada INC. |